Nickel-64 is currently used to produce Copper-64, in a cyclotron, and based on discussions with potential customers, has ...

Under the terms of the agreement, Radiopharm will use ITM’s n.c.a. 177 Lu across its clinical pipeline, including in key programs such as RAD 204 (PD-L1-targeting nanobody, Phase 1), RAD 202 ...

non-carrier-added Lutetium-177 (n.c.a. 177Lu), to enable its usage in the clinical and potential future commercial development of the 177Lu-based molecules in Radiopharm’s development pipeline.

“Lutetium-177 is required for three of our more advanced assets and this supply agreement with a radiopharmaceutical leader like ITM is another important step to ensure quality, reliability, and ...

Under the terms of the agreement, Radiopharm will use ITM’s n.c.a. 177 Lu across its clinical pipeline, including in key programs such as RAD 204 (PD-L1-targeting nanobody, Phase 1), RAD 202 ...

Radiopharm secures lutetium-177 supply agreement View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks PSEi Composite ...

Radiopharm Theranostics Ltd, a company specializing in pharmaceutical preparations, announced today a significant step in its operations with the signing of a supply agreement for non-carrier-added ...